Variables | 6-month | 1-year | ||
---|---|---|---|---|
HR (95%CI) | p-value | HR (95%CI) | p-value | |
Age | 1.03 (1.01–1.04) | < 0.001 | 1.02 (1.01–1.03) | < 0.001 |
Male | 0.84 (0.64–1.12) | 0.230 | 0.85 (0.65–1.12) | 0.256 |
SBP | 0.98 (0.97–0.99) | 0.001 | 0.98 (0.97–0.99) | 0.001 |
DBP | 1.00 (0.99–1.01) | 0.992 | 1.00 (0.99–1.02) | 0.890 |
CCU | 0.29 (0.22–0.38) | < 0.001 | 0.28 (0.22–0.37) | < 0.001 |
Hypertension | 0.38 (0.27–0.54) | < 0.001 | 0.39 (0.27–0.55) | < 0.001 |
DM | 1.07 (0.82–1.40) | 0.632 | 1.12 (0.86–1.47) | 0.393 |
AF | 1.52 (1.16-2.00) | 0.002 | 1.48 (1.14–1.94) | 0.004 |
CHF | 1.70 (1.29–2.24) | < 0.001 | 1.73 (1.32–2.28) | < 0.001 |
CKD | 1.82 (1.39–2.39) | < 0.001 | 1.82 (1.39–2.37) | < 0.001 |
Non-STEMI | 0.75 (0.53–1.05) | 0.097 | 0.78 (0.56–1.10) | 0.153 |
HB | 0.85 (0.81–0.90) | < 0.001 | 0.85 (0.80–0.90) | < 0.001 |
Bicarbonate | 0.93 (0.89–0.97) | < 0.001 | 0.94 (0.90–0.97) | < 0.001 |
CR | 1.16 (1.11–1.21) | < 0.001 | 1.17 (1.12–1.22) | < 0.001 |
Potassium | 1.30 (1.12–1.50) | 0.001 | 1.31 (1.14–1.52) | < 0.001 |
PT | 1.03 (1.02–1.05) | < 0.001 | 1.03 (1.02–1.05) | < 0.001 |
Antiplatelet drugs | 0.30 (0.21–0.42) | < 0.001 | 0.31 (0.22–0.43) | < 0.001 |
Beta-blockers | 0.21 (0.16–0.28) | < 0.001 | 0.22 (0.17–0.29) | < 0.001 |
ACEI/ARB | 0.26 (0.18–0.37) | < 0.001 | 0.29 (0.20–0.40) | < 0.001 |
Stains | 0.27 (0.20–0.37) | < 0.001 | 0.28 (0.21–0.39) | < 0.001 |
SOFA score | 1.23 (1.19–1.27) | < 0.001 | 1.22 (1.19–1.26) | < 0.001 |
CCI | 1.17 (1.12–1.23) | < 0.001 | 1.18 (1.13–1.23) | < 0.001 |
PNI (continuous) | 0.93 (0.91–0.94) | < 0.001 | 0.93 (0.91–0.94) | < 0.001 |
PNI (categorical) |  | < 0.001 |  | < 0.001 |
 Group 1 | 4.23 (3.08–5.81) | < 0.001 | 4.43 (3.23–6.08) | < 0.001 |
 Group 2 | Reference |  | Reference |  |